Finance

Lists
Q2 2026 earnings • released • Revenue beat +9.69%
See results
PHM:BME
Pharma Mar SA
€78.35
-0.89%
(-0.70) 1D
Aug 3, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHM...
Open
€79.40
High
€79.90
Low
€77.75
Mkt. cap
1.41B
Avg. vol.
59.50K
Volume
33.01K
Dividend
1.28%
Quarterly dividend
€0.25
Ex-dividend date
Jun 7, 2023
P/E ratio
23.84
52-wk high
€105.20
52-wk low
€64.00
EPS
€3.29
Shares outstanding
18.00M
No. of employees
505
Open
€79.40
High
€79.90
Low
€77.75
Mkt. cap
1.41B
Avg. vol.
59.50K
Volume
33.01K
Dividend
1.28%
Quarterly dividend
€0.25
Ex-dividend date
Jun 7, 2023
P/E ratio
23.84
52-wk high
€105.20
52-wk low
€64.00
EPS
€3.29
Shares outstanding
18.00M
No. of employees
505
News stories
From sources across the web
About Pharma Mar SA
CEO-
Employees505
Founded1986
Headquarters-
SectorBiotechnology
Websitepharmamar.com
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
- / €0.18
Revenue / Est. (EUR)
49.60M / 45.22M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
35.66M
90.48M
42.90M
49.60M
Cost of goods sold
2.30M
3.77M
3.66M
4.73M
Cost of revenue
2.30M
3.77M
3.66M
4.73M
Research and development expenses
22.13M
25.59M
20.88M
26.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.63M
17.31M
15.31M
17.12M
Operating expense
37.32M
43.09M
38.62M
46.28M
Total operating expenses
39.62M
46.87M
42.28M
51.01M
Operating income
-3.96M
43.61M
622.00K
-1.40M
Other non operating income
-
-
-
1.39M
EBT including unusual items
-4.08M
44.28M
1.60M
-993.00K
EBT excluding unusual items
-4.08M
44.28M
1.60M
-993.00K
Income tax expense
24.00K
-15.39M
65.00K
-21.00K
Effective tax rate
-0.59%
-34.75%
4.07%
2.11%
Other operating expenses
8.56M
195.00K
2.43M
2.77M
Net income
-4.10M
59.66M
1.53M
-972.00K
Net profit margin
-11.50%
65.95%
3.57%
-1.96%
Earnings per share
-
-
-
-
Interest and investment income
-
3.44M
976.00K
-
Interest expense
-117.00K
-724.00K
-
-976.00K
Net interest expenses
-117.00K
2.72M
976.00K
-976.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.95M
45.64M
2.71M
700.00K
Gain or loss from assets sale
-10.00K
-754.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps